Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boyne

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
JBJS Reviews|August 7, 2023
Team Approach: Improving Orthopaedic Operating Room EfficiencyMiho J Tanaka, Rashmi Prasad, Lauren A Miller, et al.
Clinical Breast Cancer|November 15, 2024
Real World Evidence Study to Assess Incidence, Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Early-Stage, High-Risk HER2-Negative Breast Cancer in Alberta, CanadaJan-Willem Henning, Devon J Boyne, Darren R Brenner, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 1, 2017
Impact of airflow limitation in chronic heart failureS Bektas, F M E Franssen, V van Empel, et al.
Cancer Treatment and Research Communications|October 30, 2025
Retrospective database analysis to assess treatment patterns, clinical outcomes, and healthcare resource utilization in metastatic or recurrent HER2-positive breast cancer in AlbertaRobert B Basmadjian, Winson Y Cheung, Devon J Boyne, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|May 10, 2011
Recombinant human bone morphogenetic protein 2 combined with an osteoconductive bulking agent for mandibular continuity defects in nonhuman primatesAlan S Herford, Mei Lu, Amanda N Buxton, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Understanding Characteristics, Treatment Patterns, and Clinical Outcomes for Individuals with Advanced or Recurrent Endometrial Cancer in Alberta, Canada: A Retrospective, Population-Based Cohort StudyDiana Martins, Dylan E O'Sullivan, Devon J Boyne, et al.
JCO Clinical Cancer Informatics|October 30, 2020
Development of a Model for Predicting Early Discontinuation of Adjuvant Chemotherapy in Stage III Colon CancerDevon J Boyne, Darren R Brenner, Tolulope T Sajobi, et al.
European Journal of Heart Failure|May 17, 2012
Tailored telemonitoring in patients with heart failure: results of a multicentre randomized controlled trialJosiane J J Boyne, Hubertus J M Vrijhoef, Harry J G M Crijns, et al.
Advances in Therapy|June 30, 2026
Matching-Adjusted Indirect Comparison of Tarlatamab for Patients with Platinum-Refractory or Platinum-Resistant Extensive-Stage Small-Cell Lung CancerFranziska Dirnberger, Sachin Patel, Devon J Boyne, et al.
Current Oncology (Toronto, Ont.)|January 22, 2024
Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Early-Stage Non-Small-Cell Lung CancerDylan E O'Sullivan, Devon J Boyne, Chelsea Ford-Sahibzada, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
JBJS Reviews|August 7, 2023
Team Approach: Improving Orthopaedic Operating Room EfficiencyMiho J Tanaka, Rashmi Prasad, Lauren A Miller, et al.
Clinical Breast Cancer|November 15, 2024
Real World Evidence Study to Assess Incidence, Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Early-Stage, High-Risk HER2-Negative Breast Cancer in Alberta, CanadaJan-Willem Henning, Devon J Boyne, Darren R Brenner, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 1, 2017
Impact of airflow limitation in chronic heart failureS Bektas, F M E Franssen, V van Empel, et al.
Cancer Treatment and Research Communications|October 30, 2025
Retrospective database analysis to assess treatment patterns, clinical outcomes, and healthcare resource utilization in metastatic or recurrent HER2-positive breast cancer in AlbertaRobert B Basmadjian, Winson Y Cheung, Devon J Boyne, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|May 10, 2011
Recombinant human bone morphogenetic protein 2 combined with an osteoconductive bulking agent for mandibular continuity defects in nonhuman primatesAlan S Herford, Mei Lu, Amanda N Buxton, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Understanding Characteristics, Treatment Patterns, and Clinical Outcomes for Individuals with Advanced or Recurrent Endometrial Cancer in Alberta, Canada: A Retrospective, Population-Based Cohort StudyDiana Martins, Dylan E O'Sullivan, Devon J Boyne, et al.
JCO Clinical Cancer Informatics|October 30, 2020
Development of a Model for Predicting Early Discontinuation of Adjuvant Chemotherapy in Stage III Colon CancerDevon J Boyne, Darren R Brenner, Tolulope T Sajobi, et al.
European Journal of Heart Failure|May 17, 2012
Tailored telemonitoring in patients with heart failure: results of a multicentre randomized controlled trialJosiane J J Boyne, Hubertus J M Vrijhoef, Harry J G M Crijns, et al.
Advances in Therapy|June 30, 2026
Matching-Adjusted Indirect Comparison of Tarlatamab for Patients with Platinum-Refractory or Platinum-Resistant Extensive-Stage Small-Cell Lung CancerFranziska Dirnberger, Sachin Patel, Devon J Boyne, et al.
Current Oncology (Toronto, Ont.)|January 22, 2024
Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Early-Stage Non-Small-Cell Lung CancerDylan E O'Sullivan, Devon J Boyne, Chelsea Ford-Sahibzada, et al.
Pageof 19